CGTX

0.58223.06%
MG

Michael Grundman

Member of Medical Advisory Board

Dr. Michael Grundman, also known as Mike, M.D., MPH, serves as Member of Medical Advisory Board at Cognition Therapeutics, Inc. since 2022. Dr. Grundman serves as the Chief Executive Officer and President at Global R&D Partners, LLC. Dr. Grundman serves as Senior Medical Adviser at ProMIS Neurosciences, Inc. He served as Chief Medical Advisor of Cognition Therapeutics, Inc. Dr. Grundman served as Clinical Consultant at NeuroGenetic Pharmaceuticals, Inc. Dr. Grundman served as Vice President of Clinical Development at Janssen Alzheimer Immunotherapy Research & Development, LLC and as Vice President of Clinical Development at Elan Pharmaceuticals. Dr. Grundman was Associate Director of the Alzheimer’s Disease Cooperative Study (ADCS) at the University of California, San Diego (UCSD). He has vast experience in clinical research in CNS disorders. He has been a Member of Clinical Advisory Board at CereSpir Incorporated since February 21, 2014. He served as a Member of Scientific Advisory Board at Intellect Neurosciences, Inc. Dr. Grundman served as a Member of the Clinical Advisory Board at Intellect Neurosciences, Inc. since May 16, 2011. He is an Adjunct Professor of Neurosciences at the University of California San Diego (UCSD). He lectures frequently at national and international scientific meetings and has published over 80 articles related to Alzheimer's disease and dementia. He is an inventor on a number of patents related to Alzheimer’s disease therapy. He received his B.A. in Biochemistry from New York University, his M.D. and Neurology training at the Albert Einstein College of Medicine and a Master of Public Health degree from Columbia University.

Positions